• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Mayo Clinic develops coronavirus test with results in 24 hours

Mayo Clinic develops coronavirus test with results in 24 hours

March 16, 2020 By Sean Whooley

Mayo Clinic  announced that it has developed a test to detect the SARS-CoV-2 virus that causes COVID-19.

The individuals undergoing the Mayo Clinic test could receive their results within 24 hours, according to Mayo Clinic’s clinical virology laboratory director Matthew Binnicker. That compares with the several days to a week patients have been waiting for COVID-19 test results across the U.S.

All positive samples from the Mayo Clinic test are slated to be sent to the Minnesota Department of Health or CDC for follow-up testing and confirmation, according to the Rochester, Minn.-based healthcare system.

The fully validated test, titled “Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2), Molecular Detection,” will be used to provide data to the FDA for review and emergency use authorization, according to a news release.

“This test should help ease some of the burden that is currently being felt at the Centers for Disease Control and Prevention and state public health laboratories,” Mayo Clinic Laboratories president Dr. William Morice II said in the release. “We are doing everything we can to help relieve the burden during this time to provide answers for patients here in Rochester and around the world.”

The real-time polymerase chain reaction (PCR) test is designed to identify SARS-CoV-2 from a variety of clinical samples and has been validated to test respiratory samples collected from suspected COVID-19 patients. Those samples might include such as nasopharyngeal swabs, sputum, throat swabs, bronchoalveolar lavages and bronchial washings.

Mayo Clinic said it intends to follow the CDC’s recommendations for testing the virus, which would allow U.S. health care providers to send testing directly to Mayo Clinic, which will also offer the SARS-CoV-2 assay to existing clients in the U.S. and abroad if possible.

 

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA) Tagged With: coronavirus, COVID-19, FDA, Mayo Clinic

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy